These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Kavanagh D; Richards A; Fremeaux-Bacchi V; Noris M; Goodship T; Remuzzi G; Atkinson JP Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467 [No Abstract] [Full Text] [Related]
34. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome. Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815 [TBL] [Abstract][Full Text] [Related]
35. Eculizumab for atypical hemolytic-uremic syndrome. Nürnberger J; Philipp T; Witzke O; Opazo Saez A; Vester U; Baba HA; Kribben A; Zimmerhackl LB; Janecke AR; Nagel M; Kirschfink M N Engl J Med; 2009 Jan; 360(5):542-4. PubMed ID: 19179328 [No Abstract] [Full Text] [Related]
36. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. Zimmerhackl LB; Hofer J; Cortina G; Mark W; Würzner R; Jungraithmayr TC; Khursigara G; Kliche KO; Radauer W N Engl J Med; 2010 May; 362(18):1746-8. PubMed ID: 20445192 [No Abstract] [Full Text] [Related]
37. Anti-C5 as prophylactic therapy in atypical hemolytic uremic syndrome in living-related kidney transplantation. Pelicano MB; de Córdoba SR; Diekmann F; Saiz M; Herrero S; Oppenheimer F; Campistol JM Transplantation; 2013 Aug; 96(4):e26-9. PubMed ID: 23958887 [No Abstract] [Full Text] [Related]
38. Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H. Riedl M; Rosales A; Zimmerhackl LB; Jungraithmayr T Pediatr Transplant; 2011 May; 15(3):225-8. PubMed ID: 21492349 [No Abstract] [Full Text] [Related]
39. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C; J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974 [TBL] [Abstract][Full Text] [Related]
40. Familial and recurrent forms of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. Noris M; Remuzzi G Contrib Nephrol; 2001; (136):125-39. PubMed ID: 11688376 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]